Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

LUIS A PENA FIGUEROA

Allopathic & Osteopathic Physicians General Practice

NPI
1982688776
CMS profile
618820
Location
DORADO, PR

General Payments · PY2018–2024

$2,358.38

  • Reported across 59 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$558.24

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $546.58 13
Education $11.66 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $272.63 4
ABBVIE INC. $161.57 6
Janssen Pharmaceuticals, Inc $78.08 2
Genentech USA, Inc. $31.90 1
E.R. Squibb & Sons, L.L.C. $14.06 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $332.27 6
PY2019 $338.89 9
PY2020 $50.00 2
PY2021 $75.00 3
PY2022 $623.02 15
PY2023 $380.96 10
PY2024 $558.24 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $22.71 03/11/2024 Food and Beverage Undisputed 01/23/2026 1105230146 CMS
ABBVIE INC. $25.66 05/15/2024 Food and Beverage Undisputed 01/23/2026 1105230150 CMS
ABBVIE INC. $33.14 07/29/2024 Food and Beverage Undisputed 01/23/2026 1105230154 CMS
ABBVIE INC. $28.46 08/26/2024 Food and Beverage Undisputed 01/23/2026 1105230158 CMS
ABBVIE INC. $26.55 09/09/2024 Food and Beverage Undisputed 01/23/2026 1105230162 CMS
ABBVIE INC. $25.05 12/18/2024 Food and Beverage Undisputed 01/23/2026 1105230166 CMS
AstraZeneca Pharmaceuticals LP $118.75 02/13/2024 Food and Beverage Undisputed 01/23/2026 1104243465 CMS
AstraZeneca Pharmaceuticals LP $23.51 08/07/2024 Food and Beverage Undisputed 01/23/2026 1104731125 CMS
AstraZeneca Pharmaceuticals LP $118.71 09/11/2024 Food and Beverage Undisputed 01/23/2026 1104733643 CMS
AstraZeneca Pharmaceuticals LP $11.66 11/04/2024 Education Undisputed 01/23/2026 1104642165 CMS
E.R. Squibb & Sons, L.L.C. $14.06 07/18/2024 Food and Beverage Undisputed 01/23/2026 1101245500 CMS
Genentech USA, Inc. $31.90 11/06/2024 Food and Beverage Undisputed 01/23/2026 1133056844 CMS
Janssen Pharmaceuticals, Inc $52.74 02/02/2024 Food and Beverage Undisputed 01/23/2026 1078167347 CMS
Janssen Pharmaceuticals, Inc $25.34 06/14/2024 Food and Beverage Undisputed 01/23/2026 1078167361 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.